v3.26.1
Shareholders' Equity (Deficit):
6 Months Ended
Jun. 27, 2026
Shareholders' Equity (Deficit):  
Shareholders' Equity (Deficit):

8. Shareholders’ Equity (Deficit):

Dividends

On January 28, 2026, the Company’s Board of Directors approved the payment of a $0.96 per share quarterly cash dividend to shareholders of record at the close of business on February 11, 2026, which was paid on March 2, 2026.

On April 15, 2026, the Company’s Board of Directors approved the payment of a $1.02 per share quarterly cash dividend to shareholders of record at the close of business on May 13, 2026, which was paid on June 1, 2026.

Repurchase of Common Stock

During the first six months of 2026, the Company did not repurchase shares of its common stock. Under the Board of Directors’ authorization, as of June 27, 2026, the Company has the ability to repurchase an additional 70,656 shares of its common stock. Repurchases may be made from time to time at prevailing prices, subject to certain restrictions on volume, pricing and timing.

Stock Option Plans and Stock-Based Compensation

Stock option activity under the Company’s option plans as of June 27, 2026 was as follows:

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Weighted Average

  ​ ​ ​

Remaining

Number of

Weighted Average

Contractual Life

 

Shares

 

Exercise Price

 

(years)

 

 

Intrinsic Value

Outstanding, December 27, 2025

 

315,002

$

238.30

Granted

 

32,868

377.89

Exercised

 

(15,218)

149.12

Forfeited

 

(1,671)

358.52

Outstanding, June 27, 2026

 

330,981

$

255.65

5.77

$

54,435,200

Exercisable, June 27, 2026

 

238,613

$

207.37

4.53

$

50,344,300

The fair value of options granted under the Option Plans during the first six months of 2026 and 2025 were estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions and results:

Six Months Ended

Six Months Ended

  ​ ​ ​

June 27, 2026

June 28, 2025

  ​ ​ ​

Risk free interest rate

 

4.26

%

4.10

%

 

Expected life (years)

 

6.7

6.0

 

Expected volatility

 

28.78

%

30.14

%

 

Dividend yield

 

3.06

%

2.51

%

 

Option fair value

$

97.36

$

117.14

All unexercised options at June 27, 2026 have an exercise price equal to the fair market value on the date of the grant.

Compensation expense of $1,228,300 and $1,065,600 relating to the vested portion of the fair value of stock options granted was expensed to “Selling, General and Administrative Expenses” in the first six months of 2026 and 2025, respectively. As of June 27, 2026, the Company had $8.0 million of total unrecognized compensation expense related to stock options that is expected to be recognized over the remaining weighted average vesting period of approximately 4.0 years.